Generics Industry Prescribes Remedies For EU Regulatory Sprawl
This article was originally published in Scrip
Over the 50 years that the EU pharmaceutical legislation has been in place, great progress has been made in terms of improving the quality, safety and efficacy of medicines, and a significant effort has been expended in building a strong European regulatory structure and harmonized European standards.
You may also be interested in...
Progress is being made towards the implementation of the EU’s new patent system, but the UK’s insistence on severing all ties with the European Court could spell the end for its participation.
The recruitment process for the new executive director of the European Medicines Agency seems to be running to schedule.
Russia’s new drug traceability system won’t now be implemented until July, but companies that are ready and able are being encouraged to put the system through its paces in order to flush out any glitches.